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Background
Ukraine occupies a leading position in Europe on HIV,
HCV and HBV infections. 197083 cases of HIV infection
and 2000000 cases of viral hepatitis are officially
reported among Ukrainians.
Specialists of the Kiev regional AIDS center and other
regional AIDS centers of Ukraine with the assistance of
the “EW BIOPHARMA” company (by order of “Aldima
SA”) are conducting a study on genotyping HIV, HCV
and HBV.
Methods and test-systems
- ELISA testing (Genscreen ULTRA HIV Ag-Ab; Mono-
lisa HCV Ag-Ab ULTRA; Monolisa HBs Ag Ultra)
- PCR testing (Versant HIV-1 RNA 3,0(bDNA); RMS
CAP CTM HCV PCR; Abbott Real Time HCV; Ampli-
prepCOBAS TaqMan HCV Test; AmpliSense HCV
Monitor FRT; RMS CAP CTM HBV PCR)
- Genotyping (Trugene HIV-1 Genotype; Versant
HCV v2,0 (Lipa); AmpliSense HCV- genotype FL;Quest
HBV_Genotype)
Duration of a study - August 2011 - present time.
All patients gave their voluntary consent to involve-
ment and publication of the results. The study includes
patients with HIV, or HCV, or HBV. Co-infected
patients, which was confirmed by ELISA testing, were
excluded.
200 samples have been tested during 4 mounths of
2011. Among them:
- HIV-58
- HCV-121
- HBV-21
In the genotyping of 58 samples of HIV patients were
revealed:
- M,A -21 (36,2%)
- M,B -8 (13,8%)
- M-1 (1,7%
- no genotype - 28(48,3%) (undetectable viral load)
In the genotyping of 121 samples of HCV patients
were revealed:
- 1a-2(1,6%)
- 1b-51(42,1%)
- 2a-1(0,8%)
- 2ac-1(0,8%)
- 3a-35(28,8%)
- 4-1(0,8%)
- no genotype - 30(25,1%) (undetectable viral load)
In the genotyping of 21 samples of HBV patients were
revealed:
- A-3(14,2%)
- C-1(4,7%)
- D-11(52,4%)
- no genotype - 6(28,7%) (undetectable level of viral
load)
Conclusion
Among the samples of plasma of HIV patients, the most
common genotype is -M,A (36,2%)
Among the samples of plasma of patients with HCV,
the most common genotype is 1b -(42,1%)
Among the samples of plasma of patients with HBV,
the most common genotype is D-(52,4%)
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